Oligonucleotide Synthesis Market,By Equipment and Services (Equipment/Synthesizer, Reagents, Services, ), By Technology, By Nucleic Acid, By Application, By End User, By Geography

Description

The global oligonucleotide synthesis market is estimated to be valued at US$ 3.81 Billion in 2023 and is expected to exhibit a CAGR of 10.9% during the forecast period (2023-2030).

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 3.81 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	10.90%	2030 Value Projection:	US$ 7.87 Bn

Figure 1. Global Oligonucleotide Synthesis Market Share (%), By Equipment and Services, 2023

Oligonucleotide therapeutics have revolutionized the pharmaceutical industry. They are a class of drugs and are composed of short strands of RNA or DNA that can be modified during synthesis in order to alter the expression of a number of disease-causing proteins.

Market players are interested in receiving approval from the regulatory authorities, and this is expected to drive the growth of the global oligonucleotide synthesis market over the forecast period. For instance, in the year 2021, the U.S. Food and Drug Administration approved Inclisiran. Inclisiran is being developed by the Medicines Company, a subsidiary of Novartis AG, a pharmaceutical company, which licensed the rights to inclisiran from Alnylam Pharmaceuticals, an American biopharmaceutical company. Inclisiran is indicated for the treatment of cardiovascular disease and thus demonstrates the opportunity oligonucleotides present as a treatment modality for large patient populations targeting a breadth of common diseases, including cardiovascular disease, oncology, and metabolic disorders. Currently, a number of manufacturers are conducting research and development activities for the development of oligonucleotide drugs.

Market Dynamics

Market players are engaged in conducting inorganic activities such as acquisitions in order to increase their customer base. This is expected to have a positive impact on the growth of the global oligonucleotide synthesis market over the forecast period. For instance, in January 2021, Sixfold Bioscience, a U.K.-based preclinical-stage biotechnology company, and OLIGOMED, a multidisciplinary project, announced a partnership to develop oligonucleotide therapeutics. Sixfold Bioscience also received funding from Marie Sklodowska-Curie, Innovative Training Network (ITN) to enroll PhD students in early-stage research (ESR) to improve Sixfold's in vivo oligonucleotide delivery technology.

Key features of the study:

This report provides an in-depth analysis of the global oligonucleotide synthesis market and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global oligonucleotide synthesis market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Twist Bioscience, STA Pharmaceutical Co. Ltd., KINOVATE LIFE SCIENCES, CUSABIO TECHNOLOGY LLC, Synbio Technologies, GENEWIZ, Agilent Technologies, Inc., Maravai LifeSciences Holdings, Inc., Biogen, Eurofins Scientific, Sarepta Therapeutics, Inc., LGC Limited, Kaneka Corporation, Biotage and Nitto Denko Corporation
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global oligonucleotide synthesis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global oligonucleotide synthesis market

Oligonucleotide Synthesis Market Detailed Segmentation:

By Equipment and Services:
- Nucleic Acid Synthesizer
- Peptide Synthesizer
- Oligo synthesis
- Modification
- Purification
- Equipment/Synthesizer
- Reagents
- Services
By Technology:
- Column-based
- Microarray-based
By Nucleic Acid:
- DNA
- RNA
By Application:
- Drug Discovery
- Therapeutics
By End User:
- Academic Research Institutes
- Diagnostic Laboratories
- Pharmaceutical-biotechnology Companies
By Region:
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
Company Profiles
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Twist Bioscience
- STA Pharmaceutical Co. Ltd.
- KINOVATE LIFE SCIENCES
- CUSABIO TECHNOLOGY LLC
- Synbio Technologies
- GENEWIZ
- Agilent Technologies, Inc.
- Maravai LifeSciences Holdings, Inc.
- Biogen
- Eurofins Scientific
- Sarepta Therapeutics, Inc.
- LGC Limited
- Kaneka Corporation
- Biotage
- Nitto Denko Corporation

Product Code: CMI4257

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Equipment and Services
- Market Snippet, By Technology
- Market Snippet, By Nucleic Acid
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Recent Test Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Oligonucleotide Synthesis Market - COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Oligonucleotide Synthesis Market, By Equipment and Services, 2018- 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Equipment and Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
- Nucleic Acid Synthesizer
- Peptide Synthesizer
Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
- Oligo Synthesis
- Modification
- Purification

6. Global Oligonucleotide Synthesis Market, By Technology, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
ColuBn-based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Microarray-based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends

7. Global Oligonucleotide Synthesis Market, By Nucleic Acid, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
DNA
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
RNA
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends

8. Global Oligonucleotide Synthesis Market, By Application, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Drug Discovery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Therapeutics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends

9. Global Oligonucleotide Synthesis Market, By End User, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Academic Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Pharmaceutical-biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends

10. Global Oligonucleotide Synthesis Market, By Region, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
North America
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Equipment and Services, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Nucleic Acid, 2018-2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Equipment and Services, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Nucleic Acid, 2018-2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Equipment and Services, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Nucleic Acid, 2018-2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Equipment and Services, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Nucleic Acid, 2018-2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Equipment and Services, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Nucleic Acid, 2018-2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Equipment and Services, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Nucleic Acid, 2018-2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2018 -2030, (US$ Bn)
North Africa
Central Africa
South Africa

11. Competitive Landscape

Company Profiles
- Thermo Fisher Scientific Inc.*
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Merck KGaA
- Danaher Corporation
- Twist Bioscience
- STA Pharmaceutical Co. Ltd.
- KINOVATE LIFE SCIENCES
- CUSABIO TECHNOLOGY LLC
- Synbio Technologies
- GENEWIZ
- Agilent Technologies, Inc.
- Maravai LifeSciences Holdings, Inc.
- Biogen
- Eurofins Scientific
- Sarepta Therapeutics, Inc.
- LGC Limited
- Kaneka Corporation
- Biotage
- Nitto Denko Corporation

12. Section

References
Research Methodology
About us and Sales Contact